# 68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer

> **NCT05134064** · — · COMPLETED · sponsor: **RenJi Hospital** · enrollment: 66 (actual)

## Conditions studied

- PET/CT
- Prostate Specific Membrane Antigen
- IMAGE

## Interventions

- **DEVICE:** total-body PET/CT

## Key facts

- **NCT ID:** NCT05134064
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2021-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05134064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05134064, "68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05134064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*